Skip Nav Destination
1-3 of 3
Keywords: HMG-CoA reductase inhibitorsClose
Pharmacology (2011) 88 (1-2): 1–9.
Published Online: 25 June 2011
...Si-Hyung Yang; Jun-Shik Choi; Dong-Hyun Choi The present study was designed to investigate the effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (atorvastatin, pravastatin, simvastatin) on the pharmacokinetics of losartan and its active metabolite EXP-3174 in rats...
Yukiko Ichida, Goji Hasegawa, Michiaki Fukui, Hiroshi Obayashi, Mitsuhiro Ohta, Aya Fujinami, Kiyoe Ohta, Koji Nakano, Toshikazu Yoshikawa, Naoto Nakamura
Pharmacology (2006) 76 (1): 34–39.
Published Online: 07 December 2005
... Chemistry, Kobe Pharmaceutical University, Kobe, d Department of Clinical Research Center, Utano National Hospital, and e Department of Internal Medicine, Yamashiro Hospital, Kyoto, Japan Key Words Resistin Adipokines HMG-CoA reductase inhibitors Atherosclerosis Insulin resistance Abstract Resistin...
Pharmacology (2005) 73 (2): 102–105.
Published Online: 05 January 2005
...Anna Tavridou; Vangelis G. Manolopoulos Several lines of evidence indicate that HMG-CoA reductase inhibitors, calcium channel blockers, and angiotensin-converting enzyme inhibitors exert anti-atherogenic effects in vitro and in vivo. In the present study, we determined the effect of members...